BridgeMD
New treatment option for Multiple Sclerosis, MS
Official title A Palliative Care Model Impact on Knowledge and Attitudes
ClinicalTrials.gov ID: NCT06860932
What this study is testing
- What it's testing
- This study is using a central, computer-generated simple randomization technique. Participants will be randomly assigned to groups within the constraints of ensuring balanced representation of gender, ethnicity, and race.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Diagnosed with MS, NMOSD, or anti-MOG, at least 2 years after their diagnosis.
- Aged 18-65
- Speak English since all instruments are available in English.
You likely can't join if
- Visually impaired (note, hearing impaired is not an exclusion criterion as the video is closed captioned).
- Psychological state not appropriate for PC discussions as determined by the Patient Health Questionnaire 9 (PHQ9).
- A score of 11 or higher, indicative of major depressive disorder, will be referred to immediate management and excluded from the study.
- Unable to participate in PC discussions due to cognitive impairment as determined by the Processing Speed Test (PST) score below -1.5 Z score.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.